Abionyx Pharma (CHIX:ABNXP) Cash Flow for Dividends: €0.00 Mil (TTM As of Dec. 2025)


CHIX:ABNXP Abionyx Pharma CHIX:ABNXP
15 GF Score
Price €1.73
GF Value €0.70
! 4 Warning Signs
View Full Analysis

What is Abionyx Pharma Cash Flow for Dividends?

Abionyx Pharma CHIX:ABNXP 15 Cash Flow for Dividends is €0.00 Mil as of Dec. 2025. GuruFocus rates CHIX:ABNXP with a GF Score™ of 15/100 and a GF Value™ of €0.70. The stock has 4 warning signs investors should review.

Abionyx Pharma's cash flow for dividends for the six months ended in Dec. 2025 was €0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Abionyx Pharma Cash Flow for Dividends Related Terms

Abionyx Pharma Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Abionyx Pharma's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abionyx Pharma Cash Flow for Dividends Chart

Abionyx Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Abionyx Pharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:ABNXP
15GF Score
Abionyx Pharma CHIX:ABNXP
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abionyx Pharma Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €0.00 Mil mean?
Abionyx Pharma (CHIX:ABNXP) has a Cash Flow for Dividends of €0.00 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Abionyx Pharma and its competitors.
Is Abionyx Pharma's Cash Flow for Dividends too high?
Abionyx Pharma's current Cash Flow for Dividends is €0.00 Mil. Overall, Abionyx Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Abionyx Pharma's Cash Flow for Dividends compare to VRTX and REGN?
Abionyx Pharma's Cash Flow for Dividends of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Abionyx Pharma and its competitors. Abionyx Pharma's current Cash Flow for Dividends is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abionyx Pharma stock overvalued right now?
Abionyx Pharma (CHIX:ABNXP) has a current Cash Flow for Dividends of €0.00 Mil. The stock's GF Value™ is €0.70, compared to a current price of €1.73 — trading 147.4% above its estimated fair value. The current Cash Flow for Dividends is €0.00 Mil. Abionyx Pharma's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Abionyx Pharma (CHIX:ABNXP), the current Cash Flow for Dividends is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abionyx Pharma (CHIX:ABNXP) Overvalued in 2026?

Based on GuruFocus' analysis, Abionyx Pharma stock appears to be overvalued. The current stock price of €1.73 is trading 147.4% above its estimated GF Value™ of €0.70.

Key valuation signals for CHIX:ABNXP:

  • Cash Flow for Dividends: €0.00 Mil
  • GF Value™: €0.70 vs. price of €1.73 (147.4% above fair value)
  • GF Score™: 15/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ABNXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abionyx Pharma Business Description

Address 33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.
15GF Score

Get the complete analysis for CHIX:ABNXP

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.73
Price
€0.70
GF Value